Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 9 hours agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 21 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 13 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 10 hours agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
Scientists are testing mRNA vaccines to protect cows and people against bird flu
Associated Press via Yahoo News· 4 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 17 hours agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal cancer. The vaccine...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 4 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair analyst Myles...